| 摘要 |
<p>The present invention relates to a melanin concentrating hormone antagonist compound of Formula I: (I) wherein Ar<1>, Ar<2>, Ar<3>, L<1>, L<2> and Q areas defined, or a pharmaceutically acceptable salt, solvate, enantiomer or mixture of diastereomers thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and Related Diseases.</p> |
| 申请人 |
ELI LILLY AND COMPANY;GILLIG, JAMES, RONALD;HEINZ, LAWRENCE, JOSEPH;KINNICK, MICHAEL, DEAN;LAI, YEN-SHI;MORIN, JOHN, MICHAEL, JUNIOR;SNYDER, NANCY, JUNE |
发明人 |
GILLIG, JAMES, RONALD;HEINZ, LAWRENCE, JOSEPH;KINNICK, MICHAEL, DEAN;LAI, YEN-SHI;MORIN, JOHN, MICHAEL, JUNIOR;SNYDER, NANCY, JUNE |
